Fundz

Illumina to acquire SomaLogic for $350 million

Jun 23, 2025

Acquiring Company

Illumina Cambridge Limited

Acquired Company

SomaLogic

CambridgeBoulderresearchInformation TechnologyHealth Care

Description

Illumina, Inc. has announced its intention to acquire SomaLogic for $350 million in cash, aimed at strengthening its position in the proteomics market. The acquisition will complement Illumina's existing product lines and enhance its multiomics strategy. The deal includes support for performance-based milestones and is expected to close in the first half of 2026, subject to regulatory approvals.

Quick answer

Illumina Cambridge Limited is acquiring SomaLogic for $350 million, announced June 23, 2025. Illumina Cambridge Limited is based in Cambridge, England, United Kingdom.

How much did Illumina Cambridge Limited pay for SomaLogic?
The reported deal value is $350 million.
What does Illumina Cambridge Limited do?
Illumina Cambridge Limited is a subsidiary of Illumina, Inc., a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function.
Where are Illumina Cambridge Limited and SomaLogic based?
Illumina Cambridge Limited is based in Cambridge, England, United Kingdom. SomaLogic is based in Boulder, Colorado, United States.
Who are the decision-makers at Illumina Cambridge Limited?
Fundz holds 4 contacts at Illumina Cambridge Limited. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in research and Health Care

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Illumina Cambridge Limited, and when

When Illumina Cambridge Limited changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Illumina Cambridge Limited raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Illumina Cambridge Limited, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Illumina Cambridge Limited. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Illumina Cambridge Limited

Location

5200 Illumina Way

Cambridge, England, United Kingdom

About

Illumina Cambridge Limited is a subsidiary of Illumina, Inc., a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. The company's innovative products are used for genetic research and analysis across academic, clinical, and commercial markets. They focus on enabling discoveries in the life sciences and improving patient outcomes through genomic data.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Illumina Cambridge Limited makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Charles
Likely contact at this company
••••••••@••••••••

See Charles's verified email →

John
Likely contact at this company
••••••••@••••••••

See John's verified email →

Christine
Likely contact at this company
••••••••@••••••••

See Christine's verified email →

Mark
Likely contact at this company
••••••••@••••••••

See Mark's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Illumina Cambridge Limited's next move

Learn about Strategic plan

Frequently asked

Who acquired SomaLogic?

SomaLogic was acquired by Illumina Cambridge Limited, based in Cambridge. The deal was reported on June 23, 2025. Illumina Cambridge Limited is a subsidiary of Illumina, Inc., a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. Illumina Cambridge Limited is privately held and operates in research.

When did Illumina Cambridge Limited acquire SomaLogic?

Illumina Cambridge Limited's acquisition of SomaLogic was reported on June 23, 2025. Illumina, Inc. has announced its intention to acquire SomaLogic for $350 million in cash, aimed at strengthening its position in the proteomics market. The acquisition will complement Illumina's existing product lines and enhance its multiomics strategy. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does SomaLogic do?

SomaLogic (Nasdaq: SLGC) seeks to deliver precise, meaningful, and actionable health-management information that empowers individuals worldwide to continuously optimize their personal health and wellness throughout their lives. It is privately held, operating in Information Technology, and is based in Boulder.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.